EUVIMEDDescubrir EUVIMED
Open access · CC BY 4.0

Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels

Mikael G. Abgaryan, Elena V. Artamonova, Elena I. Kovalenko, Tatyana A. Titova, Maksim P. Nikulin, Sergei N. Berdnikov, Ivan S. Stilidi

Science and Innovations in Medicine · 2026-03-28 · 11 (2) · 117-122

DOI: 10.35693/sim703846 ↗

At a glance

Journal article in Science and Innovations in Medicine, published online on 2026-03-28. Written by Mikael G. Abgaryan and 6 co-authors. 29 references. The full text is freely available (open access, CC BY 4.0).

ResumenDatos bibliográficosCiteRelated studies

Abstract (original language)

Aim: to demonstrate the feasibility, safety, and efficacy of resection of major arteries (aorta, right/left iliac artery) and veins (inferior vena cava, right/left iliac vein) in patients with retroperitoneal non-organ liposarcomas with major vessel invasion. Material and methods. This retrospective study included patients with retroperitoneal non-organ liposarcomas with major vessel invasion who underwent surgical treatment at the N.N. Blokhin National Medical Research Center of Oncology from 2001 to 2023. This included liposarcoma removal with multi-organ resection and resection of major arteries (aorta, right/left iliac artery) and veins (inferior vena cava, right/left iliac vein). Gore-Tex synthetic grafts were used for vascular reconstruction. In the presence of satisfactory collateral outflow, a circular resection of the inferior vena cava without grafting was performed. Complications of surgical treatment were assessed using the Clavien-Dindo scale. Statistical analysis of the study material was performed using Statistica for Windows v.10 and SPSS v21. Differences in the obtained results were considered statistically significant at a p level of ≤0.05. Survival was calculated using the Kaplan-Meier method, and the significance of differences was assessed using the log-rank test.

Results

The study included 28 patients with retroperitoneal non-organ liposarcomas with invasion of the great vessels: 9 (32.1%) men and 19 (67.9%) women, aged 22 to 73 years (median age 49.5 [42.5; 55.0] years). Eleven patients (39.3%) had a primary tumor, and 17 (60.7%) had a recurrent tumor. In 13 patients (46.4%), liposarcoma corresponded to stage Ib according to the TNM classification, in 6 (21.4%), stage IIIa, and in 9 (32.1%), stage IIIb. Multinodular liposarcoma was diagnosed in 12 cases (42.9%). In 13 patients (46.4%), the tumor had a high degree of differentiation (G1), in 7 (25%), moderate grade (G2), and in 8 (28.6%), low grade (G3). Neoadjuvant chemotherapy (doxorubicin + ifosfamide) was received by 6 patients (21.4%) with a stabilizing effect. All 28 patients underwent radical surgery. Along with liposarcoma removal, resection of the main arteries (aorta, right/left iliac artery) was performed in 9 (32.1%) cases, resection of the main veins (inferior cava, right/left iliac veins) in 13 (46.5%) cases, and resection of arteries and veins in 6 (21.4%) cases. Multiorgan resections of 1-5 organs were performed in 21 (75%) patients. The incidence of surgical complications of class III according to the Clavien-Dindo scale and above was 21.4% (n=6), postoperative mortality was 3.6% (n=1). The follow-up periods for 28 patients ranged from 2.3 to 189.8 months (median 62.5 [14.8; 84.6] months). During this time, disease progression occurred in 20 (71.4%) patients, local recurrence developed in 12 (42.9%), distant metastases in 7 (25%), and both local recurrence and distant metastases in 1 (3.6%). Eight (28.6%) patients died from liposarcoma progression. The overall 1- and 3-year survival rates were 96.4±3.5%, 5-year survival rates were 84.4±8.5%, and 10-year survival rates were 39.8±14.6% (median overall survival was 88.8 [72.3; -] months). The progression-free survival rates of liposarcoma were 84.8±7.0%, 48.9±11.2%, 21.7±9.5%, 5.4±5.3% and 21.7 [12.2; 52.5] months, respectively. Multivariate Cox regression analysis showed that the overall survival of 28 patients with retroperitoneal non-organ liposarcoma with invasion of great vessels was negatively affected by 3 independent factors: low degree of tumor differentiation, the presence of multinodular tumor and the presence of tumor invasion of organs located near the retroperitoneal non-organ liposarcoma, for which multiorgan resection was performed. Progression-free survival in retroperitoneal non-organ liposarcoma with great vessel invasion was statistically significantly negatively impacted by two independent factors: low tumor differentiation and the presence of tumor recurrence.

Conclusion

The results of our study demonstrated that radical surgical treatment of patients with retroperitoneal non-organ liposarcoma with great vessel invasion, including the aorta, is feasible in a specialized clinic. This treatment is associated with an acceptable complication rate and ensures a high overall 5-year survival rate of 84.4±8.5%.

Cite

APA

Abgaryan, M. G., Artamonova, E. V., Kovalenko, E. I., Titova, T. A., Nikulin, M. P., Berdnikov, S. N., & Stilidi, I. S. (2026). Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels. Science and Innovations in Medicine, 11(2), 117-122. https://doi.org/10.35693/sim703846

Vancouver

Abgaryan MG, Artamonova EV, Kovalenko EI, Titova TA, Nikulin MP, Berdnikov SN, et al. Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels. Science and Innovations in Medicine. 2026;11(2):117-122. doi:10.35693/sim703846

BibTeX
@article{Abgaryan2026,
  author = {Abgaryan, Mikael G. and Artamonova, Elena V. and Kovalenko, Elena I. and Titova, Tatyana A. and Nikulin, Maksim P. and Berdnikov, Sergei N. and Stilidi, Ivan S.},
  title = {Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels},
  journal = {Science and Innovations in Medicine},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {117--122},
  doi = {10.35693/sim703846}
}
Start for free →